Drug Updates

Conservation of Drugs: The Impact of Acute Immunomodulator Prescribing for COVID-19 on Rheumatology Patients

May 23, 2022 • By Sara Jo Santangelo, PharmD candidate, & Wendy Ramey, BSPharm, RPh, CSP

Medication Preferences & Current Practices for PsA

May 11, 2022 • By Michele B. Kaufman, PharmD, BCGP

Denosumab vs. Zoledronate: An Analysis of Treatments for Low Bone Mineral Density in Patients with HIV

May 9, 2022 • By Michele B. Kaufman, PharmD, BCGP

Anifrolumab Promising for Sustained Low Disease Activity in Patients with Lupus

May 5, 2022 • By Michele B. Kaufman, PharmD, BCGP

Pre-Eclampsia Risk & Rheumatic Disease

April 21, 2022 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Risankizumab-rzaa for PsA

April 20, 2022 • By Michele B. Kaufman, PharmD, BCGP

Is Hydroxychloroquine Safe During Pregnancy?

March 31, 2022 • By Arthritis & Rheumatology

The Ins & Outs of Patient Assistance Programs

March 3, 2022 • By Samantha C. Shapiro, MD

Drug Transference in Pregnancy: RheumMadness 2022 TNFi in Cord Blood Scouting Report

March 2, 2022 • By University of Chicago Medicine: Lauren He, MD; & Cuoghi Edens, MD

Improving Bone Mineral Density: Risedronate vs. Denosumab

March 2, 2022 • By Michele B. Kaufman, PharmD, BCGP

1
2
3
…
119
Next Page »